News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Meyer Colin John
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2023 |
4
| Meyer Colin John (Chief Innovation Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 81,633 shares
@ $0
Disposed/sold 74,304 options to buy
@ $0
Disposed/sold 24,000 options to buy
@ $121.29, valued at
$2.9M
Disposed/sold 30,000 options to buy
@ $27.32, valued at
$819.6k
Disposed/sold 70,000 options to buy
@ $27.32, valued at
$1.9M
Disposed/sold 95,475 options to buy
@ $36.71, valued at
$3.5M
Disposed/sold 90,000 options to buy
@ $22.57, valued at
$2M
Disposed/sold 87,700 options to buy
@ $24.75, valued at
$2.2M
Disposed/sold 35,500 options to buy
@ $55.73, valued at
$2M
Disposed/sold 17,750 options to buy
@ $55.73, valued at
$989.2k
Disposed/sold 25,000 options to buy
@ $207.2, valued at
$5.2M
|
|
| 08/17/2023 |
4
| Meyer Colin John (Chief Innovation Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 2,144 shares
@ $169.0687, valued at
$362.5k
Sold 596 shares
@ $168.7401, valued at
$100.6k
|
|
| 07/10/2023 |
4
| Meyer Colin John (Chief Innovation Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 6,000 shares
@ $0 |
|
| 05/17/2023 |
4
| Meyer Colin John (Chief Innovation Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 4,469 shares
@ $84.7568, valued at
$378.8k
Sold 1,139 shares
@ $85.7728, valued at
$97.7k
Sold 625 shares
@ $80.944, valued at
$50.6k
|
|
| 03/08/2023 |
4
| Meyer Colin John (Chief Innovation Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 621 shares
@ $84.57, valued at
$52.5k
|
|
| 03/06/2023 |
4
| Meyer Colin John (Chief Innovation Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Converted 88,636 shares
@ $0
Sold 22,752 shares
@ $85.23, valued at
$1.9M
Sold 34,794 shares
@ $86.49, valued at
$3M
Sold 19,099 shares
@ $87.55, valued at
$1.7M
Sold 11,181 shares
@ $88.5, valued at
$989.5k
Sold 810 shares
@ $90.58, valued at
$73.4k
Sold 5,286 shares
@ $87.35, valued at
$461.7k
Exercised 88,636 options to buy
@ $11, valued at
$975k
Converted 88,636 options to buy
@ $0 |
|
| 03/01/2023 |
4
| Meyer Colin John (Chief Innovation Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 15,000 shares
@ $0
Granted 30,000 options to buy
@ $27.32, valued at
$819.6k
|
|
| 01/04/2023 |
4
| Meyer Colin John (Chief Innovation Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 23,513 shares
@ $0
Granted 95,475 options to buy
@ $36.71, valued at
$3.5M
|
|
| 01/05/2022 |
4
| Meyer Colin John (Chief Research Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 35,000 shares
@ $0
Granted 70,000 options to buy
@ $27.32, valued at
$1.9M
|
|
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2020 |
4
| Meyer Colin John (Chief Research Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Converted 18,605 shares
@ $0
Sold 12,174 shares
@ $170.4778, valued at
$2.1M
Sold 3,824 shares
@ $171.3826, valued at
$655.4k
Sold 2,207 shares
@ $172.6065, valued at
$380.9k
Sold 100 shares
@ $173.75, valued at
$17.4k
Sold 200 shares
@ $174.98, valued at
$35k
Sold 100 shares
@ $175, valued at
$17.5k
Converted 6,395 shares
@ $0
Sold 2,450 shares
@ $164.4439, valued at
$402.9k
Sold 1,815 shares
@ $165.2463, valued at
$299.9k
Sold 1,930 shares
@ $166.1364, valued at
$320.6k
|
|
| 11/10/2020 |
4
| Meyer Colin John (Chief Research Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 25,000 shares
@ $175, valued at
$4.4M
|
|
| 01/06/2020 |
4
| Meyer Colin John (Chief Medical Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $207.2, valued at
$5.2M
|
|
| 12/17/2019 |
4
| Meyer Colin John (Chief Medical Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Converted 69,828 shares
@ $0
Converted 69,828 options to buy
@ $0 |
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Meyer Colin John (Chief Medical Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 35,500 options to buy
@ $55.73, valued at
$2M
|
|
| 12/13/2017 |
4
| Meyer Colin John (Chief Medical Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Exercised 2,351 options to buy
@ $7.86, valued at
$18.5k
Exercised 827 options to buy
@ $8.11, valued at
$6.7k
Exercised 11,822 options to buy
@ $11.62, valued at
$137.4k
|
|
| 12/07/2017 |
4
| Meyer Colin John (Chief Medical Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 87,700 options to buy
@ $24.75, valued at
$2.2M
|
|
| 12/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/02/2016 |
4
| Meyer Colin John (See Remarks) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Converted 10,172 shares
@ $0
Bought 10,000 shares
@ $11, valued at
$110k
Converted 10,172 options to buy
@ $0 |
|
| 05/26/2016 |
4
| Meyer Colin John (See Remarks) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 113,636 options to buy
@ $11, valued at
$1.2M
|
|
|
|